Details of the Drug Formulaction

General Information of Drug Formulation (ID: F11031)

• Formulation Name: Lamivudine 100 mg tablet
• Company: Camber Pharmaceuticals; Kaiser Foundation Hospitals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Lamivudine	(DMI347A)	Chronic HBV infection	1E51.0Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Crospovidone	(E00626)	Not Available	Disintegrant
Eisenoxyd	(E00585)	56841934	Colorant
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Isomalt	(E00383)	88735	Binding agent; Coating agent; Diluent; Flavoring agent; Suspending agent
Isopropyl alcohol	(E00070)	3776	Antimicrobial preservative; Solvent
Magnesium stearate	(E00208)	11177	lubricant
Polysorbate 80	(E00665)	Not Available	Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent